Position in BBNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$16,820,992
+$7,475,559 QoQ
Shares Held
1,073,452
+15.1% QoQ
Ownership
2.39%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 133 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBNX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $16,489,599,157 across 124 Medical Devices names. BBNX ranks #41 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
39,219,337 | $3,558,762,638 | |
| 2 | SYK |
Stryker Corp
|
7,819,802 | $2,461,986,461 | |
| 3 | MDT |
Medtronic plc
|
30,192,015 | $2,361,921,333 | |
| 4 | BSX |
Boston Scientific Corp
|
33,440,102 | $1,427,223,552 | |
| 5 | EW |
Edwards Lifesciences Corp
|
15,437,251 | $1,396,453,724 | |
| 6 | DXCM |
Dexcom Inc
|
12,426,515 | $836,925,784 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
12,871,800 | $823,923,917 | |
| 8 | STE |
STERIS plc
|
2,615,842 | $550,817,849 |
All Filings in BBNX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,820,992 | 1,073,452 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $9,345,433 | 932,678 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $28,077,007 | 921,464 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $18,231,777 | 917,553 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,556,260 | 312,930 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,745,648 | 306,017 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||